Prosecution Insights
Last updated: May 29, 2026

Vrije Universiteit Brussel

14 pending office actions • 12 art units • 14 examiners • 0 of 14 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days

Portfolio Summary

14
Total Pending OAs
14
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
0
Due this week
3
Due this month
3
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 30 days (3)Due ≤ 60 days (3)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (36%)
5
Easy (36%)
4
Unknown (29%)

Rejection Statute Mix

BucketCases
§103 only4 (29%)
§102 only1 (7%)
§112 only5 (36%)
No statute on record4 (29%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

11
Life Sciences
79% of docket
0
Information Tech
0% of docket
1
Communications
7% of docket
1
Semiconductors
7% of docket
1
Mechanical / Eng
7% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

140 h
Manual time on pending OAs
28 h
Time saved (low, 20%)
49 h
Time saved (mid, 35%)
1.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SINGH, AMNEET 1 79.2% +7.4%
STEVENS, MARK V 1 65.4% +42.8%
RAMADAN, OMAR 1 22.8% +64.1%
KIM, KIHO 1 85.5% +4.2%
THOMAS, NATALIE NICOLE 1
MELCHIOR, JAMES RYLAND 1 61.0% +44.6%
CHHAY, BONIRATH 1 100.0% +0.0%
WANG, CHANG YU 1 33.6% +53.0%
BORGEEST, CHRISTINA M 1 55.4% +22.1%
BOWLES, DAVID PAUL 1 75.0% +17.5%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18521703 SENSOR TIP AND METHOD OF MANUFACTURING THE SAME KIM, KIHO 87d overdue
18259155 HUMAN CCR8 BINDERS CHHAY, BONIRATH 53d

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18571904 Means and Methods for Selection of Specific Binders RAMADAN, OMAR 8d overdue

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18688085 Methods for Isolation of Lipid-Disc Compositions and Uses Thereof STEVENS, MARK V 67d overdue
18571904 Means and Methods for Selection of Specific Binders RAMADAN, OMAR 8d overdue
18269380 IMMUNE CHECKPOINTS BORGEEST, CHRISTINA M 4d overdue
18258102 G PROTEIN PEPTIDOMIMETICS BOWLES, DAVID PAUL 4d overdue
18259141 NON-BLOCKING HUMAN CCR8 BINDERS WANG, CHANG YU 41d
18275986 SARBECOVIRUS BINDERS MELCHIOR, JAMES RYLAND 69d

Top Art Units

Art UnitApps
1675 3
2633 1
1613 1
1678 1
2884 1
3774 1
1644 1
1645 1
1654 1
1642 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18956914 DIGITAL POLAR TRANSMITTER, METHOD FOR IMPROVING A DIGITAL POLAR TRANSMITTER, AND CORRESPONDING COMPUTER PROGRAM SINGH, AMNEET 2633 §102 Non-Final OA 28d overdue Pending Nov 22, 2024
18688085 Methods for Isolation of Lipid-Disc Compositions and Uses Thereof STEVENS, MARK V 1613 §103 Non-Final OA 67d overdue Pending Feb 29, 2024
18571904 Means and Methods for Selection of Specific Binders RAMADAN, OMAR 1678 Other Non-Final OA 8d overdue Pending Dec 19, 2023
18521703 SENSOR TIP AND METHOD OF MANUFACTURING THE SAME KIM, KIHO 2884 §103 Non-Final OA 87d overdue Pending Nov 28, 2023
18289824 Improved Prosthesis, Exoskeleton, and Orthosis Devices and Method of Manufacturing Thereof THOMAS, NATALIE NICOLE 3774 §103 Non-Final OA 46d Pending Nov 07, 2023
18275986 SARBECOVIRUS BINDERS MELCHIOR, JAMES RYLAND 1644 §112 Non-Final OA 69d Pending Aug 04, 2023
18259155 HUMAN CCR8 BINDERS CHHAY, BONIRATH 1645 §112 Non-Final OA 53d Pending Jun 23, 2023
18259141 NON-BLOCKING HUMAN CCR8 BINDERS WANG, CHANG YU 1675 §112 Non-Final OA 41d Pending Jun 23, 2023
18269380 IMMUNE CHECKPOINTS BORGEEST, CHRISTINA M 1675 §112 Non-Final OA 4d overdue Pending Jun 23, 2023
18258102 G PROTEIN PEPTIDOMIMETICS BOWLES, DAVID PAUL 1654 §112 Non-Final OA 4d overdue Pending Jun 16, 2023
18255433 AN LTBR AGONIST IN COMBINATION THERAPY AGAINST CANCER MACFARLANE, STACEY NEE 1675 §103 Non-Final OA 29d Pending Jun 01, 2023
18034037 ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS STONEBRAKER, ALYSSA RAE 1642 Other Non-Final OA 26d Pending Apr 26, 2023
17911041 A MIXTURE OF MRNA TO ENHANCE THE POTENCY OF DENDRITIC CELLS LEONARD, ARTHUR S 1631 Other Non-Final OA 15d Pending Sep 12, 2022
17291656 PORE STEADMAN, DAVID J 1656 Other Non-Final OA 30d overdue Pending May 06, 2021

Managing Vrije Universiteit Brussel's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month